Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension

NCT04951284 · clinicaltrials.gov ↗
TERMINATED
Status
42
Enrollment
INDUSTRY
Sponsor class

Stopped Study only continued to 2 year follow-up.

Conditions

Sponsor

Novoic Limited